drugset / Trial / NCT05583773

SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction

NCT05583773 ↗

Phase 4 Recruiting 336 enrolled China-Japan Friendship Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to conduct a multicenter, randomized clinical trial to evaluate the effect of "ShengXian-QuYu Decoction" on quality of life , symptoms, and biomarkers in heart failure patients with reduced and mildly reduced ejection fraction.

Timeline

Start
2023-03-29
Primary completion
2025-08-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator ShengXian-QuYu Decoction Unknown 30 ml Oral

Indications